BUY Sportking India Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)2 Nov 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·6 Nov · yesterday
Sportking India Limited reported strong Q2 FY27 financial results, with revenue growing 24.5% YoY to Rs 781.1 crore and PAT surging 240.9% YoY to Rs 96.4 crore.
NSE · Press Release·30 Oct · 1w ago
Sportking India Ltd reported strong Q2 FY27 financial results, with revenue growing 24.5% YoY to Rs 781.1 crore and PAT surging 240.9% YoY to Rs 96.4 crore.
BSE · Company Update·30 Oct · 1w ago
Sportking India Limited reported standalone unaudited financial results for the quarter and half year ended September 30, 2026, showing a profit of Rs 9,636.12 lakhs for the quarter.
NSE · Outcome of Board Meeting·30 Oct · 1w ago
Sportking India Ltd reported standalone unaudited financial results for the quarter and half year ended September 30, 2026, showing a profit of Rs 9,636.12 lakhs for the quarter.
BSE · Board Meeting·30 Oct · 1w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Sportking India
All analyst calls on Sportking IndiaMore from ICICI Securities
- BUY ICICI Bank5 Nov 2026 · ~1 year · target ₹1,800 · Active
- BUY Stylam Industries5 Nov 2026 · ~1 year · target ₹3,750 · Active
- BUY Emcure Pharmaceuticals5 Nov 2026 · ~1 year · target ₹2,560 · Active
- BUY Saregama India5 Nov 2026 · ~1 year · target ₹740 · Active
- BUY Procter & Gamble Health4 Nov 2026 · ~1 year · target ₹6,680 · Active

